Biochem Pharma (BCHE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (732)	4/4/2000 2:56:00 PM
From: Jim Oravetz	Read Replies (2) of 783

BioChem seen as long-term bet by Leonard Zehr - Tuesday, April 4, 2000 BioChem Pharma Inc. shares are getting ready for a snappy rebound, if you believe the past five years count for anything. Then again, maybe not. During that stretch, the stock has traded by and large in a range between $30 and $45, with many upticks preceding a quarterly earnings report and many downticks reflecting higher-than-expected spending for new drug development with precious little to show for it so far...... globeinvestor.com Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next